等待开盘 08-24 09:30:00 美东时间
0.000
0.00%
(来源:拇指药略) 走在无人之境 作者:西北哽 从昨晚到今天,整个医药圈都在沸腾。Moderna公司在8月19日晚公布:与默沙东联合开发的mRNA个性...
08-20 20:42
BioNTech(BNTX)2026年第二季度营收1.056亿欧元,同比下降约59.5%;IFRS净亏损8.208亿欧元,稀释EPS为-3.24欧元,公司同时下调全年营收和调整后研发费用指引。
08-05 06:40
BioNTech shares fall after Q1 revenue miss and wider net loss, despite lower-than-expected loss and long-term cost-saving plans.
05-06 00:18
Inventiva (IVA) appointed Axel-Sven Malkomes as chief financial officer. Former CFO Jean Volatier becomes EVP Finance & CSR. Malkomes brings 30+ years of experience, including prior roles at CureVac a...
04-23 04:21
CureVac ( ($CVAC) ) just unveiled an update. On January 6, 2026, CureVac N.V. c...
01-06 19:29
BioNTech完成对CureVac的收购,收购比例达86.75%,剩余股份将于2026年1月通过强制收购完成。此次收购将增强BioNTech在mRNA设计、递送配方和生产方面的能力。CureVac将继续运营,BioNTech将进行战略分析以确定未来架构。
2025-12-18 09:45
BioNTech announced that the minimum condition for its exchange offer of CureVac shares has been met, with approximately 81.74% of CureVac's outstanding shares tendered. The subsequent offering period has begun and will expire on December 18, 2025. BioNTech will now deliver ADSs or cash to tendering CureVac shareholders, completing the transaction. Non-tendering holders will receive ADSs through the post-offer reorganization, subject to a 15% Dutc...
2025-12-03 14:01
CureVac ( ($CVAC) ) just unveiled an announcement. On November 25, 2025, CureVa...
2025-11-26 23:27